Answers are grounded in this paper and cite their sources.
Liver fibrosis, a major histopathological indicator of chronic liver injury, is also a key feature of metabolic dysfunction-associated steatohepatitis. Its quantitative assessment in preclinical toxicology is frequently inconsistent and subjective. This study aimed to develop and validate multi-scale, patch-based convolutional neural network classification algorithms for automated fibrosis quantification in a carbon tetrachloride (CCl4)-induced mouse model. We sought to determine the optimal patch size for accurate predictions. Accordingly, male C57BL/6 mice (n = 19) were categorized into the following three groups: vehicle control (n = 5), high-fat diet (HFD) and CCl4 positive control (n = 9), and HFD and CCl4 with elafibranor (ELA) treatment (n = 5). Liver tissues were stained with Sirius-red, digitized as whole slide images, and cropped into patches of 32 × 32, 64 × 64, or 128 × 128 pixels. Each algorithm was trained, validated, and tested in an 8:1:1 ratio over 40 epochs with a batch size of 32 to classify fibrotic, normal, and background regions. All models performed robustly, with validation accuracies exceeding 98% and F1-scores above 0.96. Particularly, the 32 × 32 model exhibited the highest correlation with pathologist’s measurements (Spearman’s r = 0.9609; p < 0.05) and the most accurate estimation of absolute fibrotic area compared to expert assessments. This model also accurately detected the antifibrotic effects of ELA. These findings establish that the 32 × 32 patch-based classification approach provides a rapid, reproducible, and objective method for liver fibrosis quantification in preclinical toxicology, with strong potential for integration into digital pathology workflows.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: